...
首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: Feasibility and early results
【24h】

Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: Feasibility and early results

机译:经皮导管内射频消融治疗恶性胆道梗阻清除闭塞金属支架的可行性和早期结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: The major complication occurring with biliary stents is stent occlusion, frequently seen because of tumour in-growth, epithelial hyperplasia, and sludge deposits, resulting in recurrent jaundice and cholangitis. We report a prospective study with the results of first in man percutaneous intraductal radiofrequency (RF) ablation to clear the blocked metal stents in patients with malignant biliary obstruction using a novel bipolar RF catheter. Methods: Nine patients with malignant biliary obstruction and blocked metal stents were included. These patients underwent intraductal biliary RF ablation through the blocked metal stent following external biliary decompression with an internal-external biliary drainage. Results: All nine patients had their stent patency restored successfully without the use of secondary stents. Following this intervention, there was no 30-day mortality, haemorrhage, bile duct perforation, bile leak, or pancreatitis. Of the nine patients, six are alive and three patients are dead with a median follow-up of 122 (range 50-488) days and a median stent patency of 102.5 (range 50-321) days. Six patients had their stent patent at the time of last follow-up or death. Three patients with stent blockage at 321, 290, and 65 days postprocedure underwent percutaneous transhepatic drain insertion and repeat ablation. Conclusions: In this selective group of patients, it appears that this new approach is safe and feasible. Efficacy remains to be proven in future, randomized, prospective studies.
机译:目的:胆道支架发生的主要并发症是支架闭塞,通常由于肿瘤向内生长,上皮增生和淤渣沉积而出现,导致复发性黄疸和胆管炎。我们报告了一项前瞻性研究,其结果是首次使用新型双极RF导管进行人经皮经皮导管内射频(RF)消融术,以清除恶性胆道梗阻患者的金属支架。方法:纳入9例恶性胆道梗阻和金属支架阻塞的患者。这些患者在通过外部胆道减压并通过内部-外部胆道引流后,通过封闭的金属支架进行了导管内胆道射频消融术。结果:9例患者均在不使用辅助支架的情况下成功恢复了支架通畅。进行此干预后,没有30天的死亡率,出血,胆管穿孔,胆漏或胰腺炎。在这9名患者中,有6名还活着,有3名患者死亡,中位随访时间为122(50-488)天,中位支架通畅度为102.5(50-321)天。在最后一次随访或死亡时,有6名患者获得了支架专利。 3例在手术后321、290和65天出现支架阻塞的患者,经皮经肝穿引流管插入并重复消融。结论:在这种选择性的患者中,看来这种新方法是安全可行的。疗效在未来的随机前瞻性研究中仍有待证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号